| Drug Name |
Edrophonium chloride |
| Drug ID |
BADD_D00748 |
| Description |
A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles. |
| Indications and Usage |
For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises. |
| Marketing Status |
approved |
| ATC Code |
V04CX07 |
| DrugBank ID |
DB01010
|
| KEGG ID |
D00994
|
| MeSH ID |
D004491
|
| PubChem ID |
8307
|
| TTD Drug ID |
D0S5LH
|
| NDC Product Code |
49812-0011 |
| UNII |
QO611KSM5P
|
| Synonyms |
Edrophonium | Edroponium | Edrophonium Chloride | Chloride, Edrophonium | Tensilon | Edrophonium Bromide | Bromide, Edrophonium |
